If rescheduled, cannabis would allow for tax break opportunities that cannabis businesses cannot currently access.

After it failed to pass at the end of 2022, the Secure And Fair Enforcement (SAFE) Banking Act was reintroduced by bipartisan lawmakers in both chambers of Congress.

As we anticipate the revival of federal cannabis legalization as a vital issue in the 2024  presidential elections, the cannabis industry will continue to grow throughout legal states.

The FDA recently announced it is renewing its contract with Waterloo University to conduct a cannabis study. Since 2019, the FDA and the University have conducted International Cannabis Policy Study (ICPS).

According to a recent study published in the Psychological Medicine Journal, cannabis legalization has not led to an increase in substance use disorders or increased use of other illicit drugs, and “should not be considered a ‘gateway drug.’”